You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Plerixafor

Showing 26 - 50 of 182
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Stem Cell Transplantation, Leukemia Trial in Houston (Plerixafor, Filgrastim, Fludarabine)

Completed
Has Results
  • Stem Cell Transplantation
  • Leukemia
  • Plerixafor
  • +5 more
  • Houston, Texas
    UT MD Anderson Cancer Center
Sep 22, 2020

Non-interventional Study on Salvage Auto in Relapsed Myeloma

Completed
  • Relapsed Multiple Myeloma
    • Paris, France
      Hématologie Clinique, Hôpital Saint Antoine
    Jan 19, 2021

    Transplants and Implants Trial in Cincinnati (plerixafor, Bortezomib, plasmapheresis)

    Unknown status
    • Transplants and Implants
    • plerixafor
    • +2 more
    • Cincinnati, Ohio
    • +1 more
    Jun 29, 2020

    Glioblastoma, Gliosarcoma Trial in Seattle (radiation, procedure, drug, biological, other)

    Completed
    Has Results
    • Glioblastoma
    • Gliosarcoma
    • 3-Dimensional Conformal Radiation Therapy
    • +10 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Mar 4, 2022

    Multiple Myeloma Trial in Westwood (Bortezomib, Granulocyte colony-stimulating factor (G-CSF), Mozobil)

    Completed
    Has Results
    • Multiple Myeloma
    • Westwood, Kansas
      The University of Kansas Medical Center
    May 24, 2021

    Related Donors Donating PBSC to a Family Member, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in United States

    Completed
    • Related Donors Donating PBSC to a Family Member
    • +7 more
    • Plerixafor
    • Tampa, Florida
    • +11 more
    Sep 3, 2020

    Allogeneic Hematopoietic Cell Transplantation (HCT), Advanced Hematologic Malignancies, Acute Leukemia Trial in Stanford

    Recruiting
    • Allogeneic Hematopoietic Cell Transplantation (HCT)
    • +5 more
    • Purified regulatory T-cells (Treg) plus CD34+ HSPC
    • +7 more
    • Stanford, California
      Stanford University
    Oct 28, 2021

    Multiple Myeloma Trial in United States (Plerixafor, bortezomib, Dexamethasone)

    Completed
    Has Results
    • Multiple Myeloma
    • Plerixafor
    • +2 more
    • Boston, Massachusetts
    • +4 more
    May 19, 2020

    Sickle Cell Disease Trial run by the NHLBI (Plerixafor)

    Completed
    Has Results
    • Sickle Cell Disease
    • Plerixafor
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Apr 13, 2020

    Pancreas Cancer Trial in New York, Cambridge (Plerixafor)

    Terminated
    • Pancreas Cancer
    • Plerixafor
    • New York, New York
    • +1 more
    Feb 27, 2020

    Diabetes, Wounds, Critical Limb Ischemia Trial in Padova (Plerixafor, Placebo)

    Terminated
    • Diabetes
    • +2 more
    • Plerixafor
    • Placebo
    • Padova, Italy
      University Hospital of Padova
    Dec 17, 2019

    Fanconi Anemia Trial in Barcelona, Madrid (filgrastim, plerixafor)

    Completed
    • Fanconi Anemia
    • Barcelona, Spain
    • +1 more
    May 25, 2020

    Diffuse Large B-cell Lymphoma (DLBCL), Relapsed Diffuse Large B-cell Lymphoma (DLBCL), Refractory Diffuse Large B-cell Lymphoma

    Recruiting
    • Diffuse Large B-cell Lymphoma (DLBCL)
    • +2 more
    • leukapheresis
    • +3 more
    • Omaha, Nebraska
    • +13 more
    Jan 21, 2022

    Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphocytic Leukemia Trial in Saint Louis (drug, radiation, procedure)

    Terminated
    • Acute Myeloid Leukemia
    • +2 more
    • Saint Louis, Missouri
      Washington University School of Medicine
    Oct 16, 2020

    Head Neck Cancer Trial in Boston (AMD3100, Pembrolizumab)

    Withdrawn
    • Head and Neck Cancer
    • Boston, Massachusetts
    • +1 more
    Sep 3, 2020

    Chronic Granulomatous Disease Trial in Moscow (Plerixafor, Gcsf)

    Unknown status
    • Chronic Granulomatous Disease
    • Moscow, Russian Federation
      Dmitry Rogachev National Research Center of Pediatric Hematology
    Sep 16, 2019

    Bone Marrow Transplantation, Hematopoietic Stem Cells, Multiple Myeloma Trial in Baltimore (Neupogen, Hyperbaric oxygen therapy,

    Withdrawn
    • Bone Marrow Transplantation
    • +3 more
    • Baltimore, Maryland
      University of Maryland Medical Center
    Dec 9, 2019

    Acute Myelogenous Leukemia Trial in Houston (Plerixafor, Clofarabine)

    Terminated
    Has Results
    • Acute Myelogenous Leukemia
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Aug 19, 2019

    Fanconi Anemia Trial in Barcelona, Madrid (procedure, biological, other, drug)

    Unknown status
    • Fanconi Anemia
    • IV administration of Genetically Engineered Hematopoietic Stem/Progenitors Cells (HSPCs)
    • +5 more
    • Barcelona, Spain
    • +1 more
    Nov 23, 2020

    Anemia, Sickle Cell Trial in Duarte (Autologous enriched CD34+ cell fraction that contains CD34+ cells transduced with

    Terminated
    • Anemia, Sickle Cell
    • Autologous enriched CD34+ cell fraction that contains CD34+ cells transduced with lentiviral vector encoding human γ-globinG16D and short-hairpin RNA734
    • Duarte, California
      City of Hope Medical Center
    Jun 14, 2021

    Stem Cells Mobilization, colLection and Engraftment in Newly

    Recruiting
    • Multiple Myeloma
    • +3 more
    • Rome, Italy
      Fondazione Policlinico Universitario A.Gemelli IRCCS
    Apr 28, 2023

    Study of Mast Cell Precursors

    Completed
    • Mastocytosis
    • Healthy Volunteer
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Nov 4, 2022

      Acute Myeloid Leukemia Trial in Saint Louis (Selinexor, Cladribine, G-CSF)

      Completed
      Has Results
      • Acute Myeloid Leukemia
      • Saint Louis, Missouri
        Washington University School of Medicine
      Mar 6, 2020

      Pancreatic Adenocarcinoma Metastatic, Ovarian Serous Adenocarcinoma, Colorectal Cancer Metastatic Trial in Cambridge

      Completed
      • Pancreatic Adenocarcinoma Metastatic
      • +2 more
      • Plerixafor
      • Cambridge, United Kingdom
        Addenbrookes Hospital
      Jul 19, 2019

      Multiple Myeloma Trial in Atlanta, New York (bortezomib (Velcade), cyclophosphamide, G-CSF)

      Completed
      Has Results
      • Multiple Myeloma
      • bortezomib (Velcade)
      • +3 more
      • Atlanta, Georgia
      • +4 more
      Dec 18, 2019